Skip to main content
Top
Published in: CEN Case Reports 1/2018

01-05-2018 | Case Report

Influence of thyroid function on glomerular filtration rate and other estimates of kidney function in two pediatric patients

Authors: Osamu Uemura, Naoyuki Iwata, Takuhito Nagai, Satoshi Yamakawa, Satoshi Hibino, Masaki Yamamoto, Masaru Nakano, Kazuki Tanaka

Published in: CEN Case Reports | Issue 1/2018

Login to get access

Abstract

To determine the optimal method of evaluating kidney function in patients with thyroid dysfunction, this study compared the estimated glomerular filtration rate derived from serum creatinine, cystatin C, or β2-microglobulin with inulin or creatinine clearance in two pediatric patients, one with hypothyroidism and the other with hyperthyroidism. It was observed that the kidney function decreased in a hypothyroid child and enhanced in a hyperthyroid child, with their kidney function becoming normalized by treatment with drugs, which normalized their thyroid function. Kidney function cannot be accurately evaluated using cystatin C-based or β2-microglobulin-based estimated glomerular filtration rate in patients with thyroid dysfunction, as these tests overestimated glomerular filtration rate in a patient with hypothyroidism and underestimated glomerular filtration rate in a patient with hyperthyroidism, perhaps through a metabolic rate-mediated mechanism. In both our patients, 24-h urinary creatinine secretion was identical before and after treatment, suggesting that creatinine production is not altered in patients with thyroid dysfunction. Therefore, kidney function in patients with thyroid dysfunction should be evaluated using creatinine-based estimated glomerular filtration rate.
Literature
5.
go back to reference Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000;300(1–2):83–95.CrossRefPubMed Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000;300(1–2):83–95.CrossRefPubMed
6.
go back to reference Bokenkamp A, Grabensee A, Stoffel-Wagner B, Hasan C, Henne T, Offner G, et al. The beta2-microglobulin/cystatin C ratio–a potential marker of post-transplant lymphoproliferative disease. Clin Nephrol. 2002;58(6):417 – 22.PubMed Bokenkamp A, Grabensee A, Stoffel-Wagner B, Hasan C, Henne T, Offner G, et al. The beta2-microglobulin/cystatin C ratio–a potential marker of post-transplant lymphoproliferative disease. Clin Nephrol. 2002;58(6):417 – 22.PubMed
11.
go back to reference Al-Fifi S, Girardin C, Sharma A, Rodd C. Moderate renal failure in association with prolonged acquired hypothyroidism in children. Acta Paediatr. 1999;88(7):715–7.CrossRefPubMed Al-Fifi S, Girardin C, Sharma A, Rodd C. Moderate renal failure in association with prolonged acquired hypothyroidism in children. Acta Paediatr. 1999;88(7):715–7.CrossRefPubMed
14.
go back to reference Roiter I, Da Rin G, De Menis E, Foscolo GC, Legovini P, Conte N. Increased serum beta 2-microglobulin concentrations in hyperthyroid states. J Clin Pathol. 1991;44(1):73 – 4.CrossRefPubMedPubMedCentral Roiter I, Da Rin G, De Menis E, Foscolo GC, Legovini P, Conte N. Increased serum beta 2-microglobulin concentrations in hyperthyroid states. J Clin Pathol. 1991;44(1):73 – 4.CrossRefPubMedPubMedCentral
Metadata
Title
Influence of thyroid function on glomerular filtration rate and other estimates of kidney function in two pediatric patients
Authors
Osamu Uemura
Naoyuki Iwata
Takuhito Nagai
Satoshi Yamakawa
Satoshi Hibino
Masaki Yamamoto
Masaru Nakano
Kazuki Tanaka
Publication date
01-05-2018
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2018
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-018-0320-7

Other articles of this Issue 1/2018

CEN Case Reports 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.